skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Azithromycin and erythromycin ameliorate the extent of colonic damage induced by acetic acid in rats

Journal Article · · Toxicology and Applied Pharmacology
 [1];  [1];  [1];  [2];  [3]
  1. Department of Pharmacology, College of Medicine, King Saud University, Riyadh 11461 (Saudi Arabia)
  2. Department of Pathology, College of Medicine, King Saud University, Riyadh 11461 (Saudi Arabia)
  3. Central Laboratories, Ministry of Health, Riyadh (Saudi Arabia)

Ulcerative colitis is a common inflammatory bowel disease (IBD) of unknown etiology. Recent studies have revealed the role of some microorganisms in the initiation and perpetuation of IBD. The role of antibiotics in the possible modulation of colon inflammation is still uncertain. In this study, we evaluated the effects of two macrolides, namely azithromycin and erythromycin, at different doses on the extent and severity of ulcerative colitis caused by intracolonic administration of 3% acetic acid in rats. The lesions and the inflammatory response were assessed by histology and measurement of myeloperoxidase (MPO) activity, nitric oxide synthetase (NOS) and tumor necrosis factor alpha (TNF{alpha}) in colonic tissues. Inflammation following acetic acid instillation was characterized by oedema, diffuse inflammatory cell infiltration and necrosis. Increase in MPO, NOS and TNF{alpha} was detected in the colonic tissues. Administration of either azithromycin or erythromycin at different dosage (10, 20 and 40 mg/kg orally, daily for 5 consecutive days) significantly (P < 0.05) reduced the colonic damage, MPO and NOS activities as well as TNF{alpha} level. This reduction was highly significant with azithromycin when given at a dose of 40 mg/kg. It is concluded that azithromycin and erythromycin may have a beneficial therapeutic role in ulcerative colitis.

OSTI ID:
20721804
Journal Information:
Toxicology and Applied Pharmacology, Vol. 205, Issue 1; Other Information: DOI: 10.1016/j.taap.2004.09.012; PII: S0041-008X(04)00439-9; Copyright (c) 2004 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0041-008X
Country of Publication:
United States
Language:
English